Search Results Label

Our leadership team is composed of experienced professionals with deep scientific expertise and a shared commitment to public health. Meet them now.

https://www.seqirus.us/our-company/leadership

Our leadership team is composed of experienced professionals with deep scientific expertise and a shared commitment to public health. Meet them now.

https://www.seqirus.us/our-company/leadership/gregg-sylvester

Seqirus is a global influenza vaccine company developing innovative solutions to ensure epidemic and pandemic preparedness throughout the world.

https://www.seqirus.us/our-company

The University of Queensland, CEPI and CSL partner to advance development and manufacture of COVID-19 vaccine candidate

https://www.seqirus.us/news/the-university-of-queensland-cepi-and-csl-partner-on-covid-19-vaccine-candidate

Read the latest news from Seqirus, a world leader in developing and producing influenza vaccines.

https://www.seqirus.us/news/covid19-update

Seqirus is first-to-market with shipment of seasonal influenza vaccines to the US for the 2016-2017 season

https://www.seqirus.us/news/seqirus-is-first-to-market-with-shipment-of-seasonal-influenza-vaccines-for-2016-2017-season

Seqirus partners with American Nurse Practitioner Foundation, American Pharmacists Association and Physician Assistant Foundation to drive conversation around flu prevention in adults 65 and older

https://www.seqirus.us/news/be-fluent-partnership-shines-spotlight-on-importance-of-flu-prevention-in-seniors

In an industry first, Seqirus has successfully produced cell-based influenza vaccine at commercial scale using a candidate vaccine virus (CVV) that has been isolated and grown in cells, rather than in eggs.

https://www.seqirus.us/news/seqirus-announces-next-major-advancement-in-cell-based-influenza-vaccine-technology

About Seqirus Seqirus is the new global company created in July 2015 from the combined strength and expertise of bioCSL Inc. and the influenza vaccines business formerly owned by Novartis AG.

https://www.seqirus.us/-/media/seqirus-us/news/franchise-shipment-press-release--71116final-530-pm.pdf